Some studies have suggested that GLP-1 receptor agonists might offer direct cardiovascular benefits beyond those associated with weight loss, blood pressure reduction, improved lipid profiles, and glycemic control. These include potential protective effects on the heart and vascular system, such as improved endothelial function, reduced atherosclerotic plaque formation, and decreased myocardial stress.

It is important for healthcare providers to consider the individual patient's health profile, including the presence of cardiovascular disease or risk factors, when prescribing these medication. Listen in to learn more.